Both in Medical Labs
Aclarion vs Castle Biosciences
Over the past year ACON returned −73.5% and CSTL returned +51.9%; their daily moves had a correlation of 0.14.
ACON −73.5% CSTL +51.9%Growth of $1, one year, split-adjusted
| Metric | ACON | CSTL |
|---|---|---|
| Price | $2.04 | $36.68 |
| Market cap | $5.9M | $1.12B |
| Today | +6.25% | +6.29% |
| 1 month | −14.3% | +5.2% |
| 6 months | −37.4% | +51.3% |
| Year to date | −55.7% | −5.7% |
| 1 year | −73.3% | +53.1% |
| Revenue growth (YoY) | +30.5% | +20.1% |
| Gross margin | 32.9% | 77.1% |
| Net margin | −10899.5% | −2.0% |
| P/E (TTM) | — | — |
| Price / sales | 70.2× | 3.1× |
| Net cash | $16.3M | $256.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 49.9% |
| Short % of float | 0.9% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).